Danaher

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

Retrieved on: 
Monday, October 2, 2023

WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately.

Key Points: 
  • WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately.
  • Prior to Cytiva, he worked for a combined 12 years with Lonza, advancing to Vice President Sales, Lonza Custom Manufacturing.
  • Mr. Loeillot joins Repligen from his most recent role as Chief Executive Officer (CEO) of Ascensus Specialties, a manufacturer of specialty chemicals for use in the life sciences and pharmaceutical markets.
  • Hunt, Chief Executive Officer at Repligen, said, “We are delighted to welcome Olivier to our team at Repligen.

Lifshitz Law PLLC Announces Investigations of Integra LifeSciences Holdings Corporation (NASDAQ: IART), Enviva, Inc. (NYSE: EVA), and DitigialOcean Holdings, Inc. (NYSE: DOCN), and Danaher Corp. (NYSE: DHR)

Retrieved on: 
Sunday, October 1, 2023

The Company also extended the pause on all production at the Boston Facility.

Key Points: 
  • The Company also extended the pause on all production at the Boston Facility.
  • The Company further disclosed that it expected to take a $22 million impairment charge in the second quarter due to the inventory write-off.
  • These disclosures caused the price of Integra stock to decline by an additional $10.24 per share, or 20%.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

Diebold Nixdorf Announces Four New Appointments to its Board of Directors

Retrieved on: 
Thursday, September 28, 2023

HUDSON, Ohio, Sept. 28, 2023 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD) today announced that it expanded the size of its board of directors to seven independent members plus its chief executive officer. The company also announced the recent appointment of four new, independent directors, all of whom bring significant experience in operational excellence and driving financial performance. Patrick Byrne, Matthew Espe, Mark Gross and David Naemura joined the board effective Sept. 22, 2023. Mr. Byrne was appointed as chair of the board.

Key Points: 
  • HUDSON, Ohio, Sept. 28, 2023 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD) today announced that it expanded the size of its board of directors to seven independent members plus its chief executive officer.
  • Previously, Byrne served as chief executive officer of GE Digital, where he led the company's software businesses focused on digital transformation.
  • With these most recent appointments, Diebold Nixdorf's board now consists of eight directors.
  • Patrick Byrne, incoming Diebold Nixdorf chair, said: "I am honored to take on the role of chair at such an exciting time for Diebold Nixdorf.

Danaher Schedules Third Quarter 2023 Earnings Conference Call

Retrieved on: 
Tuesday, September 26, 2023

WASHINGTON, Sept. 26, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2023 on Tuesday, October 24, 2023 beginning at 8:00 a.m.

Key Points: 
  • WASHINGTON, Sept. 26, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2023 on Tuesday, October 24, 2023 beginning at 8:00 a.m.
  • ET and notifying the operator that you are dialing in for Danaher's earnings conference call (Conference ID: DHRQ323).
  • A replay of the conference call will be available shortly after the conclusion of the call until November 8, 2023.
  • Danaher's earnings press release, the webcast slides and other related materials will be posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings" beginning at 6:00 a.m.

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

Retrieved on: 
Tuesday, September 19, 2023

Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.

Key Points: 
  • Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.
  • WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at Cepheid's cost of $7.97 each to the Global Fund to Fight AIDS, TB and Malaria ("the Global Fund") and to less-developed countries eligible for Cepheid's Global Access Program1 to support greater access to high-quality TB testing.
  • By reducing the price of Cepheid's Xpert® MTB/RIF Ultra test cartridge to $7.97, Danaher will be selling at its cost and will earn no profit.
  • The agreement significantly expands a longtime partnership between Cepheid - a Danaher operating company - and the Global Fund to improve access to testing where it matters most.

Abcam plc Statement on Dr. Jonathan Milner’s Announcement

Retrieved on: 
Thursday, September 14, 2023

Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), notes today’s announcement by Dr. Jonathan Milner.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), notes today’s announcement by Dr. Jonathan Milner.
  • All bidders were given access to the same financial information, consistent with the information the Company has made public.
  • After receiving offers from multiple bidders, Danaher’s all cash offer of $24.00 was the highest and best price.
  • Abcam is not a company subject to regulation under the City Code on Takeovers and Mergers (the “UK Takeover Code”), therefore no dealing disclosures are required to be made under Rule 8 of the UK Takeover Code by shareholders of Abcam or Danaher.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 – (NYSE: DHR)

Retrieved on: 
Wednesday, September 13, 2023

NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.

Key Points: 
  • NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.
  • Shareholders who purchased shares of DHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: September 15, 2023 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hostess Brands, Inc. (Nasdaq – TWNK), Avantax, Inc. (Nasdaq – AVTA), Thorne HealthTech, Inc. (Nasdaq - THRN), Abcam plc (Nasdaq - ABCM)

Retrieved on: 
Monday, September 11, 2023

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the merger agreement, Hostess shareholders will receive $30.00 in cash and 0.03002 shares of The J.M.
  • Smucker Co. common stock (valued at $4.25 as of September 8, 2023) for each share of Hostess common stock.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Danaher Corporation of Class Action Lawsuit and Upcoming Deadline – DHR

Retrieved on: 
Saturday, September 9, 2023

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.

Key Points: 
  • NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR), and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Danaher Corporation: Please contact the Portnoy Law Firm to recover your losses; September 15, 2023 deadline

Retrieved on: 
Friday, September 8, 2023

LOS ANGELES, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) investors that a lawsuit filed on behalf of investors that purchased Danaher securities between April 21, 2022, and April 24, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.